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There are at least five families of microbe-detection receptors that function to detect and eradicate
potentially infectious microorganisms that enter multicellular eukaryotes. While a multitude of
proteins regulating innate immune signal transduction have already been defined, continuous
genetic screening for regulators of innate immunitymay not yield as significant insight into the oper-
ation of these pathways as was obtained in the past. This diminished return on experimental invest-
ment suggests that we are approaching the asymptote of genetics-only approaches to study innate
immunity. In contrast, it remains unclear how known regulators of innate immunity interact within
the infrastructure of mammalian cells to execute their signaling functions. In this Perspective, I first
highlight the locations within mammalian cells that permit innate immune signal transduction and
then offer a model whereby structurally distinct proteins can be grouped functionally through their
ability to assemble platforms of regulators on the signaling organelles of the innate immune system.Introduction
One of the defining features of eukaryotic cells is the use of
organelles to compartmentalize biochemical activities. This
compartmentalization permits the separation of cellular func-
tions that may not otherwise coexist, such as proteolysis (which
can occur in proteasomes and lysosomes) and protein synthesis
(which occurs in ribosomes). There are numerous additional
examples of organelles being utilized to separate biochemical
activities, but one area where this idea has only recently gained
attention is in the operation of the innate immune system (Barton
and Kagan, 2009). The mammalian innate immune system is
comprised of several families of microbial detection receptors
(Akira et al., 2006), classically called pattern recognition recep-
tors (PRRs) (Janeway, 1989), which share little sequence simi-
larity. Because different PRRs are located in different subcellular
compartments (Barton and Kagan, 2009), they have the potential
to provide fascinating insight into how signal transduction path-
ways operate within the general infrastructure of a eukaryotic
cell. This Perspective will identify the organelles that permit
innate immune signal transduction and discuss the means by
which these sites are ‘‘chosen.’’ I suggest that the innate immune
system is designed to dissociate the sites of microbial detection
from the sites of signal transduction. Whereas the receptors of
the innate immune system determine the sites of microbial
detection, the sites of signaling are dictated by the localization
of distinct membrane-bound proteins called sorting adaptors.
A central conclusion of this essay is that PRRs are dependent
on the cellular trafficking machinery to be delivered to both the
sites of immune surveillance and the sites of innate immune
signal transduction. The regulators of PRR transport can there-
fore be categorized as either biosynthetic trafficking factors or
microbe-inducible trafficking factors, the latter of which has1168 Cell 151, December 7, 2012 ª2012 Elsevier Inc.only recently emerged as a critical control element for innate
immune signal transduction.
Classifying Microbe Detection Receptors Based on
Their Ability to Induce Inflammation
Some PRRs bind microbial products directly, such as the
mannose receptor, mannose-binding lectin (MBL), C-reactive
protein, serum amyloid protein, and the complement system
(Janeway and Medzhitov, 2002). A defining feature of these
receptors is that they function primarily in the extracellular
spaces of multicellular eukaryotes to promote the phagocytosis
and/or killing of microbes that they encounter. However, these
proteins are not inflammation-inducing receptors in the sense
that they have no intrinsic ability to induce the expression of
inflammatory cytokines. This latter task is accomplished by
a second class of PRRs that link microbial detection to the
expression and/or secretion of chemokines, cytokines, inter-
ferons (IFNs), and other inflammatory mediators. This class
includes the Toll-like receptors (TLRs), NOD-like receptors
(NLRs), RIG-I like receptors (RLRs), AIM2-like receptors
(ALRs), and the C-type lectin receptors of the Dectin family
(Brown and Gordon, 2001; Inohara et al., 1999; Medzhitov
et al., 1997; Unterholzner et al., 2010; Yoneyama et al., 2004).
Because the purpose of this Perspective is to discuss the sites
within mammalian cells that permit innate immune signal trans-
duction, I will focus on this latter group of ‘‘signaling’’ PRRs,
whose members can be found on multiple organelles.
The aforementioned families of signaling PRRs share little
sequence homology, and as such, bioinformatic analyses alone
would not permit the grouping of these receptors into a super-
family. However, detailed functional analysis of individual
family members revealed themes that transcend the structural
Figure 1. Organelles that Serve as Sites of Microbial Detection
Illustrated is a typical mammalian macrophage that harbors innate immune
receptors in specific subcellular locations. The subcellular sites indicated are
the sites of receptor residence prior to anymicrobial encounter. As such, these
are the most likely sites of microbial detection. At the plasma membrane
are bacterial-sensing TLRs such as TLRs 1, 2, 4, 5, and 6 and Dectins 1 and 2.
Within the endosomal network is TLR4 and the virus-sensing TLRs 3, 7, 8, 9,
and 13. The RLRs RIG-I and MDA5 and the ALR AIM2 are present in the
cytosol, and the ALR IFI16 is present in the nucleus. Bacterial-sensing NLRs
NOD1 and NOD2 are present in the inner leaflet of the plasmamembrane. Note
that the larger family of inflammasome-activating NLRs is not indicated, but
many are predicted to be cytosolic.characteristics of each protein family. For example, all signaling
PRRs exhibit the ability to recognize products of microbial
metabolism (Brown et al., 2003; Girardin et al., 2003; Pichlmair
et al., 2006; Poltorak et al., 1998; Unterholzner et al., 2010).
These products, classically defined as pathogen-associated
molecular patterns (PAMPs) (Janeway, 1989), are largely unique
to the microbial world and are often common to broad classes of
microbes. Examples of PAMPs include bacterial lipopolysac-
charide (LPS), lipoproteins, flagellin, double-stranded RNA,
unmethylated CpG-containing DNA, and RNA that contains a
triphosphorylated 50 end. For the most part, these molecular
features are absent from mammalian cells, thus allowing their
detection to indicate the presence of a microorganism (Janeway
and Medzhitov, 2002). Though many PRRs recognize PAMPs
directly (Kang and Lee, 2011; Kowalinski et al., 2011; Latz
et al., 2004), some require the assistance of accessory mole-
cules that themselves are high-affinity PAMP-binding proteins
(Gioannini et al., 2004). The second feature that is common to
all signaling PRRs is their ability to induce the activation of
proinflammatory transcription factors such as AP-1, NF-kB,and various IFN regulatory factors (IRFs) (Kumar et al., 2011).
The combinatorial actions of these transcription factors deter-
mine the precise gene expression program that is induced by
a given PRR. The third common feature of these PRRs is that
none of them are signaling enzymes yet that all induce an
enzyme-dependent signaling response that activates inflamma-
tory transcription factors. Innate immune signaling pathways
therefore enlist the help of adaptor proteins to link active recep-
tors to the downstream kinases and ubiquitin ligases to promote
inflammation.
Organelles that Permit Pathogen Detection in the Innate
Immune System
The fundamental purpose of the innate immune system is to
detect the presence of microbes and their products. This ratio-
nale has been used to explain the diversity of PAMPs that are
detected by PRRs (Medzhitov, 2009). Though we have an
increasingly detailed understanding of themolecular interactions
that occur between PAMPs and their receptors (Jin and Lee,
2008), insight into where within mammalian cells these interac-
tions occur has only begun to emerge. In fact, it is now clear
that most membrane-bound organelles harbor one or more
PRRs (Figure 1). For example, the plasmamembrane is occupied
by the transmembrane domain-containing receptors that detect
either bacterial products (e.g., TLRs 1, 2, 4, 5, and 6) or fungal
products (Dectins 1 and 2) (Brown and Gordon, 2001; Du et al.,
1999; Gewirtz et al., 2001; Ozinsky et al., 2000; Underhill et al.,
1999). Interestingly, whereas the NLR family is generally believed
to encode cytosolic proteins, NOD1 and NOD2 have been local-
ized to the inner leaflet of the plasma membrane (Barnich et al.,
2005; Travassos et al., 2010). There are two features that link all
plasma-membrane-localized PRRs. First, they detect microbial
cell surface components, such as LPS (e.g., TLR4), lipoproteins
(TLR2/1 and TLR2/6 heterodimers), flagellin (TLR5), peptidogly-
cans (NOD1 and NOD2), and fungal cell wall components
(Dectins 1 and 2) (Akira et al., 2006). It seems reasonable to
propose that the localization of these receptors to the cell
surface is linked to the ligands that they detect, as themost rapid
means of detecting microbial cell surface components would be
to localize PRRs that detect said components to the surface of
mammalian cells. The second feature that links all plasma-
membrane-localized PRRs is that they have the ability to be
recruited to sites of phagocytosis (Brown and Gordon, 2001;
Ozinsky et al., 2000; Tissie`res et al., 2008; Underhill et al.,
1999). In some instances (e.g., Dectin family members), these
receptors direct the phagocytic process (Goodridge et al.,
2012). Interestingly, at least some of these receptors (e.g.,
TLR2) can be recruited to phagosomes containing any type of
cargo (Underhill et al., 1999). Thus, it is likely that the function
of phagosomal recruitment is to determine whether microbial
cargo is present within the phagosome-to-be (Underhill et al.,
1999). Both of these features of plasma-membrane-localized
PRRs ensure rapid detection of microbial encounters in the
extracellular spaces.
The endosomal network also represents a site of PRR resi-
dence (Figure 1). For example, in addition to its plasma
membrane locale, TLR4 can be found in the early and recycling
endosomes of macrophages (Husebye et al., 2010; Kagan et al.,Cell 151, December 7, 2012 ª2012 Elsevier Inc. 1169
2008). TLRs 3, 7, 8, 9, and 13 are also found in late-endosomal
compartments (Barton and Kagan, 2009). TLR9 is the best char-
acterized in this regard, and it is found in late endosomes
harboring phosphatidylinositol (PI)-3,5 bisphosphate (PI(3,5)P2)
and in lysosome-related organelles (LROs) (Sasai et al., 2010).
With the exception of TLR4, the unifying feature of the endoso-
mal TLRs is their ability to detect microbial nucleic acids such
as double-stranded RNA (e.g., TLR3), single-stranded RNA
(TLRs 7 and 8), unmethylated CpG DNA (TLR9), or ribosomal
RNA (TLR13) (Alexopoulou et al., 2001; Diebold et al., 2004;
Hemmi et al., 2000; Hidmark et al., 2012; Oldenburg et al.,
2012). Because nucleic acids are hidden from host receptors
until the microbe is degraded, the placement of these receptors
in late endosomal vesicles likely ensures rapid detection once
they are released by the hydrolytic late endosomal environment.
Thus, just as was argued for the plasma-membrane-localized
PRRs, the localization of endosomal TLRs reflects a need for
rapid responsiveness to a microbial presence. The second
unifying feature of the endosomal TLRs (again with the exception
of TLR4) is that they are synthesized as proproteins whose
ectodomains must be cleaved by one or more endosomal
proteases to generate a signaling-competent receptor (Ewald
et al., 2008, 2011; Park et al., 2008).
Within the secretory pathway, there is limited evidence of PRR
residence other than during the biosynthetic trafficking of the
transmembrane receptors (Ewald et al., 2008). The mechanisms
by which different PRRs are delivered to post-Golgi compart-
ments such as the plasma membrane or endosomes are only
now being revealed, with the best-characterized example being
that provided by the protein Unc93B1. Unc93B1 was initially
proposed to not exhibit any transport function but, rather, to
act as a signaling protein that regulates the functions of endoso-
mal TLRs uniquely (Tabeta et al., 2006). Recent work firmly
established its primary function as a regulator of TLR trafficking
(Brinkmann et al., 2007; Kim et al., 2008). Unc93B1 binds to all
nucleic-acid-sensing TLRs after they are synthesized on the
endoplasmic reticulum (ER) and stays associated with these
proteins as they transit the secretory pathway to be delivered
to endosomes (Brinkmann et al., 2007; Kim et al., 2008).
Evidence supporting a direct transport function of Unc93B1 for
TLRs was provided by studies showing that forcing Unc93B1
localization to the cell surface also results in the delivery of
nucleic-acid-sensing TLRs to this location (Kim et al., 2008).
Thus, the biosynthetic transport of nucleic-acid-sensing TLRs
is mediated by Unc93B1. Although there is some question as
to whether all nucleic-acid-sensing TLRs occupy the same
endosomal vesicles, the fact that a single chaperone
(Unc93B1) delivers all of these receptors to endosomes and
remains associated with them makes it likely that there is signif-
icant overlap in their subcellular distribution.
In addition to Unc93B1, gp96 and PRAT4A regulate the TLR
trafficking (Takahashi et al., 2007; Yang et al., 2007). Unlike
Unc93B1, gp96 and PRAT4A regulate the transport of all TLRs.
Gp96 is an ER paralog of the Hsp90 family that acts as a chap-
erone for multiple protein substrates, including immunoglobu-
lins, some integrins, and TLRs (Yang et al., 2007). Macrophages
deficient for gp96 are unresponsive to all TLR ligands, indicating
that gp96 is required for signaling via TLRs found at both the1170 Cell 151, December 7, 2012 ª2012 Elsevier Inc.plasmamembrane and endosomes (Yang et al., 2007). Similarly,
PRAT4A-deficient cells are unresponsive to ligands from all
TLRs, except TLR3 (Takahashi et al., 2007).
Although TLRs can be found in the ER and Golgi compart-
ments, there is little evidence that these proteins can signal
from these locations. Thus, it is likely that their residence in
secretory organelles is simply a reflection of their biosynthetic
trafficking path that will lead them to an organelle poised for
exposure to microbial contents.
At a superficial level, it would seem redundant for a single cell
to express RLRs (which detect viral RNA), NLRs (bacterial prod-
ucts), and TLRs (bacterial products and viral nucleic acids).
However, these receptor families survey different compartments
of the cell. Whereas the TLRs survey the extracellular and
lumenal endosomal networks (Barton and Kagan, 2009), the
RLRs and NLRs survey the cytosol for microbial products
(Kanneganti et al., 2007; Nakhaei et al., 2009). For example,
the proinflammatory RLR family members RIG-I and MDA5 are
soluble cytoplasmic proteins that survey this compartment for
the presence of viral (and in some instances bacterial) RNA
(Nakhaei et al., 2009). Likewise, most NLRs are thought to be
cytosolic proteins (Kanneganti et al., 2007), although this family
is poorly characterized from a cell biological perspective.
When considered in the context of an actual infection, the
differential localizations of TLRs and RLRs/NLRs have functional
implications. The most common type of microbe encountered
by our innate immune system is likely to be nonpathogenic.
These microbes have the potential to compete for nutrients of
the host but encode no sophisticated weapons of colonization
or immune evasion. As such, these microbes are often recog-
nized by PRRs that survey the extracellular and endosomal envi-
ronments during the process of their removal by phagocytosis.
In contrast, pathogens, almost by definition, must interact with
host cells intimately (Lamkanfi and Dixit, 2009; Vance et al.,
2009). For bacteria, these intimate interactions are often medi-
ated by secreted protein toxins or specialized secretion systems
such as type III or type IV systems that deliver effector molecules
into the host cytosol to manipulate various signaling pathways
(Cambronne and Roy, 2006; Gala´n and Wolf-Watz, 2006). In
the case of viruses, these pathogens must enter the cytosol to
gain access to the translation machinery of the host. Thus,
a cell biological distinction between nonpathogen and pathogen
is the ability of the latter to deliver itself or its information (effec-
tors) into the host cytosol. Because all microbes are extracellular
at the earliest stage of infection, all microbes should be detected
by PRRs surveying the extracellular environment. In contrast,
RLRs and NLRs only survey the compartment that can be ac-
cessed by a pathogen (the cytosol). The activation of these
receptor families is therefore indicative of an encounter with
a virulent microbe. An example of this principle comes from
studies of the bacterium Listeria monocytogenes, which
replicates in the cytosol of mammalian cells (Cossart, 2011).
Wild-type Listeria activates PRRs that survey the extracellular
environment and PRRs that survey the cytosol (McCaffrey
et al., 2004). In contrast, Listeria mutants that cannot enter the
cytosol (and thereforemimic a nonpathogenic encounter) cannot
engage cytosolic PRRs (McCaffrey et al., 2004). Thus, TLRs and
Dectin family members can be considered microbe detection
receptors, whereas cytoplasmic RLRs and NLRs can be consid-
ered pathogen detection receptors.
The logical consistency between where PRRs are located and
where their target PAMPs are revealed to the host raises a strong
argument that the primary selective pressure for diversifying
receptor locale was to ensure rapid detection of microbial prod-
ucts. Interestingly, as will be described below, recent evidence
indicates that the site of receptor-ligand interaction is not neces-
sarily the site of innate immune signal transduction. Rather,
microbe-induced trafficking events must often occur before
a ligand-bound receptor can induce its cognate transcriptional
response.
Signaling Organelles of the Innate Immune System
It has become somewhat dogmatic to use the localization of
TLRs as an indication of where innate immune signal transduc-
tion occurs. In this section, several lines of evidence will be pre-
sented to suggest that the site of receptor-ligand interaction
does not necessarily indicate the site of signaling. Rather,
many PRRs must be transported to a second location for signal
transduction to occur.
The first example of a microbe-inducible trafficking event
came from studies of the LPS receptor TLR4 (Poltorak et al.,
1998). TLR4 is found at the plasma membrane of many mamma-
lian cell types but has been best characterized on phagocytes
such as macrophages and dendritic cells (DCs). The immunosti-
mulatory structure of LPS is lipid A, a hydrophobic motif consist-
ing of acyl chains of varying lengths and numbers (depending on
the bacteria) (Gioannini and Weiss, 2007). Lipid A is extracted
from the outer membrane of Gram-negative bacteria by the
LPS-binding protein (LBP) by a process facilitated by albumin
(Gioannini et al., 2005). LPS is then transferred to a second
LPS-binding protein called CD14 (Gioannini et al., 2004; Gioan-
nini et al., 2005), which can exist as a soluble extracellular protein
or a GPI-anchored protein attached to the outer leaflet of the
plasma membrane (Wright et al., 1990). CD14 then transfers
LPS to a high-affinity LPS-binding protein called MD-2, which
forms a stable complex with TLR4 (Gioannini et al., 2004,
2005). Recognition of LPS by TLR4-MD-2 leads to the dimeriza-
tion of the Toll-IL-1 receptor (TIR) domains present in the cyto-
solic tail of the receptor, which activates inflammatory signal
transduction (Park et al., 2009).
TLR4 signaling is initiated when its dimerized TIRs engage two
pairs of TIR-domain containing adaptor proteins that activate
distinct transcriptional responses. The adaptors MyD88 and
TIRAP activate signaling events that lead to NF-kB- and AP-1-
dependent expression of inflammatory cytokines such as IL-1b,
IL-6, and IL-12 (Horng et al., 2002; Kawai et al., 1999; Yamamoto
et al., 2002). The adaptors TRAM and TRIF activate signaling
events that lead to the IRF3-dependent expression of type I
IFNs (Yamamoto et al., 2003a, 2003b). Studies using the endocy-
tosis inhibitor dynasore (which inactivates dynamin GTPases)
revealed that LPS-induced TLR4 endocytosis was required for
activation of the TRIF pathway to type I IFNs (Kagan et al.,
2008). Subsequent work on the IFN-inducing E3 ubiquitin ligase
TRAF3 provided a biochemical explanation for this phenotype.
TLR4 endocytosis is necessary for the attachment of lysine-63
linked ubiquitin chains to TRAF3, a process that is necessaryfor its ability to propagate TRIF signaling (Tseng et al., 2010). In
contrast, endocytosis was not required for TLR4 to induce
MyD88-dependent signaling in response to LPS or Gram-nega-
tive bacteria (Kagan et al., 2008; Zanoni et al., 2011). However,
in order to induce MyD88-dependent responses, TLR4 must be
first transported to subdomains of the cell surface called lipid
rafts (Triantafilou et al., 2002). These results suggest that the
initial site of LPS detection by TLR4 (the plasma membrane) is
not the site of signaling. Rather, TLR4 must first be mobilized
into lipid rafts to induce MyD88-dependent signal transduction
and then internalized into endosomes to induce TRIF-dependent
signaling. Interestingly, TLR2 must also be delivered to lipid rafts
to promote MyD88-dependent signaling responses (Triantafilou
et al., 2006). These data suggest that a common feature of
PRRs at the cell surface is the spatial separation of sites of
ligand binding and signal transduction.
Studies of LPS-inducible TLR4 transport revealed that the
aforementioned LPS-binding protein CD14 controls these
events. CD14 is required for the delivery of TLR4 into lipid rafts
after LPS binding (Triantafilou et al., 2002), and it is required to
deliver TLR4 to endosomes (Zanoni et al., 2011). Interestingly,
the mechanism by which TLR4 is delivered to endosomes
does not require TLR4 signaling, nor does it require the TIR
domain containing adaptor proteins (Zanoni et al., 2011). Thus,
CD14 induces a novel LPS response pathway that leads to
the rapid endocytosis of TLR4, which is necessary for TRIF-
dependent signaling. This third LPS response pathway is a
calcium-dependent process that involves several general regu-
lators of cellular trafficking, such as the tyrosine kinase Syk,
the ITAM-containing adaptors DAP12 and FcεRg, and PLCg2
(Chiang et al., 2012; Zanoni et al., 2011). These data indicate
that TLR4 does not control all cellular responses to LPS; rather,
it controls all transcriptional responses to LPS. Because the
transcriptional responses induced by LPS require CD14-depen-
dent transport of TLR4 into lipid rafts and endosomes, CD14
can be considered a master regulator of TLR4-mediated signal
transduction. Thus, for MyD88-dependent signaling from the
plasma membrane, lipid rafts represent the subcellular site
where TLR4- and TLR2-dependent signaling platforms can be
assembled (Figure 2).
Recent work on the adaptor protein TRAM, which acts with
TRIF to induce TLR4-dependent IFN expression, suggests that
signaling probably occurs in early endosomes (or early phago-
somes) (Doyle et al., 2012; Husebye et al., 2010; Palsson-
McDermott et al., 2009). Evidence supporting this statement
comes from work on a splice variant of TRAM called TAG (Doyle
et al., 2012; Palsson-McDermott et al., 2009). Whereas TRAM
functions to promote TRIF signaling, TAG functions to inactivate
these signaling events (Doyle et al., 2012; Palsson-McDermott
et al., 2009). In contrast to the proinflammatory TRAM protein,
which is located on early endosomes and the plasmamembrane,
the TAG splice variant is located on late endosomes. Because
the inhibitor of this pathway is located on late endosomes, it is
likely that the early endosomal compartments are the primary
site of TRAM-TRIF-dependent signal transduction. Thus, for
TRIF-dependent signaling, early endosomes (or phagosomes)
are the subcellular site where TLR4-dependent signaling plat-
forms can be assembled (Figure 2).Cell 151, December 7, 2012 ª2012 Elsevier Inc. 1171
Figure 2. Signaling Organelles of the Innate Immune System
Illustrated is a typical mammalian macrophage that harbors innate immune
receptors in specific subcellular locations. The subcellular sites indicated are
the sites of receptor residence after microbe-induced receptor transport. The
legend indicates the type of signaling pathway activated from each location.
Note that, in most cases, the sites of receptor signaling differ from the sites of
microbial detection, as illustrated in Figure 1. At the plasma membrane rafts
are bacterial-sensing TLRs such as TLRs 1, 2, 4, 5, and 6. Within early endo-
somes is TLR4. The virus-sensing TLRs 3, 7, 8, 9, and 13 may signal from late
endosomes and lysosomes-related organelles, although this has been only
formally demonstrated for TLR9. The RLRs RIG-I and MDA5 signal from
mitochondria and peroxisomes that are docked at theMAM. Note that some of
the receptors indicated in Figure 1 are not illustrated here because not enough
information is available to define their sites of signaling.A second example of PRRs that must be transported after
ligand recognition to induce signal transduction is provided by
the CpG DNA sensor TLR9 (Hemmi et al., 2000). In most phago-
cytic cells, TLR9 signaling activates the expression of inflamma-
tory cytokines but does not induce type I IFN expression (Honda
et al., 2005). A notable exception to this principle comes from
studies of plasmacytoid dendritic cells (pDCs), within which
TLR9 induces the expression of both cytokines and IFNs (Honda
et al., 2005). Thus, in pDCs, TLR9-dependent transcriptional
responses resemble those activated by TLR4. Also like TLR4,
the site of ligand binding by TLR9 can be dissociated from the
site of signal transduction, at least in the case of IFN expression
(Sasai et al., 2010). When TLR9 is present within late endosomes
that contain PI(3,5)P2, it is capable of inducing the expression of
NF-kB-dependent cytokines such as IL-6 and IL-12 (Sasai et al.,
2010) (Figure 2). However, the ability to induce IFN expression
requires the transport of TLR9 to LROs (Figure 2). Transport of
TLR9 to LROs is mediated by a protein complex called adaptor1172 Cell 151, December 7, 2012 ª2012 Elsevier Inc.protein-3 (AP-3) (Sasai et al., 2010). Cells lacking AP-3 are
unable to deliver TLR9 to LROs, and consequently, TLR9 is
only capable of inducing the expression of cytokines; no IFNs
are expressed (Sasai et al., 2010). It remains unclear whether
PI(3,5)P2-rich endosomes are the site where TLR9 first detects
its DNA ligand, and as such, it is not known whether microbe-
induced trafficking is required for all TLR9-dependent signaling
events or just for signaling events that lead to IFN expression.
Nevertheless, it is clear that, in the case of TLRs 4 and 9, the
ability to induce IFN expression requires the movement of the
receptor to a subcellular location distinct from the initial site of
ligand binding.
The need for receptor movement to a second subcellular
location to activate signal transduction extends beyond the
endosomal network. The RLRs RIG-I andMDA5 survey the cyto-
solic compartment for the presence of viral RNA (Nakhaei et al.,
2009). RIG-I detects structures that are usually absent from host
RNAs but are common to viral RNAs, such as those containing 50
triphosphate groups, short double-stranded regions, and/or
uridine-rich 30 regions (Pichlmair et al., 2006; Saito et al., 2008;
Uzri and Gehrke, 2009). The precise ligand detected by MDA5
remains unclear, but it is generally believed that this PRR recog-
nizes long sequences of double-stranded RNA (Kato et al., 2008;
Pichlmair et al., 2009). Despite the differences in RNA structures
detected by these RLRs, a common mechanism of signaling
pathway activation exists. RLR activation occurs via the sequen-
tial binding of RNA and unanchored lysine-63-linked polyubiqui-
tin chains (Jiang et al., 2012). Polyubiquitin binding by RLRs
promotes their oligomerization, which somehow leads to the
activation of inflammatory cytokines and IFNs.
There are no clear ‘‘rules’’ to explain when and where during
the life cycle of viruses their RNA is exposed to the cytosol. As
such, it is unknown exactly where in the cell RLRs first detect
viral RNA. Because the life cycles of RNA viruses are incredibly
diverse, it is likely that RLRs detect viral RNA present in many
locations. Once viral RNA is recognized, RLRs must engage an
adaptor protein called MAVS, which is a tail-anchored protein
that is located on the limiting membranes of mitochondria,
peroxisomes, and mitochondria-associated ER membranes
(MAM) (Dixit et al., 2010; Horner et al., 2011; Seth et al., 2005).
Thus, although RLRs probably have the ability to detect RNA in
many locations of the cell, these PRRs must be transported to
the aforementioned organelles to promote MAVS-dependent
signaling (Figure 2). Recent work indicates that, upon binding
to viral RNA, RIG-I forms a complex with the E3 ubiquitin ligase
TRIM25 and the cytosolic chaperone 14-3-3ε (Gack et al.,
2007; Liu et al., 2012). Whereas in wild-type cells, RNA binding
likely causes the transport of RIG-I to membrane fractions that
likely contain MAM/mitochondria and peroxisomes (Dixit et al.,
2010; Horner et al., 2011), this transport event is defective in cells
lacking 14-3-3ε (Liu et al., 2012). Thus, like the TLRs, the subcel-
lular sites of RLR-ligand interaction can be dissociated from the
sites of signal transduction, and the movement between these
two locations is a regulated event.
A final example of microbe-induced receptor transport comes
from recent work on the innate immune responses to intracellular
(i.e., cytosolic or nuclear) DNA. Although the identity of the
sensor(s) of intracellular DNA remains unclear, ample evidence
exists to support a role for the endoplasmic reticulum (ER)-local-
ized protein STING (Ishikawa and Barber, 2008; Ishikawa et al.,
2009). STING has the ability to bind both the IFN-inducing
transcription factor IRF3 and its upstream kinase TBK1 (Tanaka
and Chen, 2012). The ability of STING to bind both of these
factors probably facilitates IRF3 phosphorylation, which leads
to its translocation into the nucleus, where type I IFN expression
can be induced. The importance of STING in antiviral innate
immunity is underscored by findings that STING-deficient cells
are unable to induce type I IFN or IFN-stimulated gene (ISG)
expression in response to numerous DNA viruses and some
bacteria (Ishikawa and Barber, 2008; Ishikawa et al., 2009).
STING has been proposed to serve as either an adaptor protein
that is engaged by upstream DNA-binding receptors or a direct
sensor of bacterial cyclic dinucleotides (Burdette et al., 2011;
Ishikawa and Barber, 2008; Ishikawa et al., 2009). Thus, for
the purpose of this discussion, STING can be considered
a ‘‘receptor.’’ Upon DNA transfection or viral infection, STING
will move from the ER to poorly characterized vesicles that
contain the IRF3 kinase TBK1 (Ishikawa et al., 2009; Saitoh
et al., 2009). Blocking the transport of STING either genetically
or pharmacologically prevents the expression of type I IFNs
and ISGs in response to transfected DNA (Ishikawa et al.,
2009; Saitoh et al., 2009). Although the mechanism of DNA-
induced STING transport remains unclear, these data suggest
that, like the cytosolic sensors of viral RNA (RLRs), the cellular
machinery involved in DNA detection must also be transported
to a second subcellular site to induce signal transduction.
Recent work on herpes simplex virus (HSV) infections sug-
gests that STING is not the only protein that must be inducibly
transported for innate immune signaling to occur. HSV is an
enveloped virus that injects genomic DNA into the host nucleo-
plasm. This nuclear viral DNA then activates innate immune
signaling pathways that depend on STING (Orzalli et al., 2012).
The protein IFI16 is a member of the newest family of PRRs,
called AIM2-like receptors (ALRs) (Unterholzner et al., 2010).
ALRs detect viral DNA, with the founding family member AIM2
functioning in the cytosol to induce inflammasome activation
after DNA sensing (Rathinam et al., 2010). IFI16 recognizes
HSV DNA in the host cell nucleus and is required for the
STING-dependent expression of IFNs and ISGs after infection
(Li et al., 2012; Orzalli et al., 2012). This suggests that the site
of HSV DNA detection by IFI16 (nucleus) is distinct from the
site of signaling (cytosol). It is therefore possible that IFI16 (or
some other nuclear factor) is transported to the cytosol by
a specific chaperone to induce STING/TBK1-mediated gene
expression.
To conclude this section, it is worth noting that, in most/all
of the examples listed above, it is likely that both the receptor
and its microbial ligand are transported to a signaling-competent
organelle. How can one distinguish the importance of receptor
transport from ligand transport for the induction of cytokine
and antiviral gene expression? In this regard, studies of TLR4
in CD14-deficient macrophages have proved informative. In
wild-type macrophages, both LPS and TLR4 will be internalized
into endosomes that are competent for TRIF-dependent signal
transduction. CD14-deficient macrophages, in contrast, inter-
nalize neither LPS nor TLR4. Interestingly, CD14-deficientmacrophages are able to internalize LPS-coated beads (or
Gram-negative bacteria), but they will not permit the endocytosis
of TLR4 (Zanoni et al., 2011). Under these conditions, TRIF
signaling does not occur. These data therefore provide definitive
proof that the receptor itself (TLR4) must be delivered to endo-
somes in order to initiate TRIF signaling.
Molecules that Identify Signaling Organelles
of the Innate Immune System
The above examples illustrated that several distinct families of
PRRs must be delivered to an organelle distinct from the site
of ligand binding to promote signal transduction. In this section,
several lines of evidence will be presented to indicate that the
site of signal transduction is defined by a structurally diverse
set of membrane proteins called sorting adaptors.
Generally, sorting adaptors are defined as signaling proteins
that are located at the site of signal transduction prior to any
microbial encounter. In contrast, upstream receptors and down-
stream signaling proteins are not often found at the sites of
signaling prior to microbial detection. Sorting adaptors are
therefore unique in that they serve as a cell biological ‘‘landmark’’
that identifies the subcellular site of signal transduction.
Microbe-inducible delivery of a PRR to an organelle harboring
the correct sorting adaptor leads to the recruitment of down-
stream regulatory proteins to activate signal transduction. The
prepositioning of sorting adaptors at the sites of signaling
is important, as mislocalization of these adaptors to different
subcellular compartments renders the innate immune signaling
pathway defective.
The proteins TIRAP and TRAM represent the known sorting
adaptors in the TLR system (Kagan andMedzhitov, 2006; Kagan
et al., 2008). As described above, these adaptors function
together with other TIR-domain-containing proteins to promote
TLR4 signaling. TIRAP acts together with MyD88 to induce
NF-kB-dependent cytokine expression downstream of plasma-
membrane-localized TLR4 and TLR2 (Horng et al., 2002;
Yamamoto et al., 2002). TRAM acts with TRIF to induce IRF3-
dependent type I IFN expression downstream from endosomal
TLR4 (Yamamoto et al., 2003b). Whereas the upstream recep-
tors must rely on microbe-induced trafficking factors for their
delivery to lipid rafts and endosomes to induce signal trans-
duction (Triantafilou et al., 2002, 2006; Zanoni et al., 2011), the
sorting adaptors TIRAP and TRAM are positioned at these loca-
tions at steady state (Kagan and Medzhitov, 2006; Kagan et al.,
2008). TIRAP localizes to PI(4,5)P2-rich regions of the plasma
membrane, such as membrane ruffles and lipid rafts, by means
of an N-terminal phosphoinositide-binding motif that selectively
binds to PI(4,5)P2 (Kagan and Medzhitov, 2006). TRAM is local-
ized to the plasma membrane and early endosomes through the
actions of a bipartite localization domain consisting of an
N-terminal myristoylation sequence and an adjacent phosphoi-
nositide-binding domain (Kagan et al., 2008; Rowe et al.,
2006). Mutations that abolish the integrity of the localization
domains in TIRAP or TRAM render these proteins cytosolic (Ka-
gan and Medzhitov, 2006; Kagan et al., 2008; Rowe et al., 2006).
Under these conditions, TLR4 signaling is defective (Kagan and
Medzhitov, 2006; Kagan et al., 2008; Rowe et al., 2006), even
though these conditions do not prevent CD14-dependentCell 151, December 7, 2012 ª2012 Elsevier Inc. 1173
transport of TLR4 (Zanoni et al., 2011). Thus, microbe-induced
transport of TLR4 is not sufficient for signaling to occur. The sort-
ing adaptors must be localized in the appropriate organelle in
order to detect the receptor and assemble a platform for signal
transduction.
Recent work indicates that, although TRAM functions from en-
dosomes to assemble a signaling platform for TLR4-dependent
TRIF signaling, it has a distinct function at the plasma mem-
brane. From this latter location, TRAM facilitates the signaling
events activated by the interleukin-18 receptor (IL-18R), a TLR
superfamily member (Ohnishi et al., 2012). These results provide
a potential explanation for why TRAM is located in two subcel-
lular locations: it has distinct sorting adaptor functions from
each. Additional work remains to be done to determine whether
a cytokine-induced trafficking event is needed to deliver IL-18R
to the as-yet undefined subdomain of the plasmamembrane that
harbors TRAM. In addition to the IL-18R, the better understood
IL-1R (another TLR superfamily member) may use a sorting
adaptor to signal from the plasma membrane. Binding of
the IL-1R to its cytokine ligand IL-1b induces the transport of
this receptor to a subdomain of the plasma membrane called
caveolae (Blanco et al., 2008; Liu and Anderson, 1995). It is
from caveolae that MyD88-dependent cytokine expression is
induced. Relative to lipid rafts and sites of phagocytosis, caveo-
lae contain low (but detectable) levels of PI(4,5)P2 (Watt et al.,
2002). Thus, the sorting adaptor TIRAP should not be concen-
trated in caveolae, which may explain why TIRAP is not required
for IL-1R signaling (Horng et al., 2002; Yamamoto et al., 2002).
Rather, a distinct sorting adaptor may assemble platforms for
IL-1R signaling from caveolae. Detailed biochemical analysis
suggests that the IL-1R accessory protein (IL-1RacP) is a core
component of the IL-1R signaling complex (Brikos et al., 2007).
Although this protein has some role in ligand binding, its most
impressive function is to act together with MyD88 to induce
signal transduction (Brikos et al., 2007; Korherr et al., 1997;
Radons et al., 2002). In this regard, IL-1RacP is similar to TIRAP
and TRAM in that it acts with a downstream adaptor to assemble
a signaling platform in a specific subcellular location. For this
reason, I speculate that the plasma membrane contains at least
three sites of innate immune/cytokine signaling, and each site
contains a unique sorting adaptor. The three sites are: (1)
PI(4,5)P2-rich lipid rafts occupied by TIRAP, (2) PI(4,5)P2-poor
caveolae occupied by IL-1RacP, and (3) an unknown compart-
ment occupied by TRAM.
In addition to the TLR and cytokine receptors, the RLR family
also appears to utilize sorting adaptors to define the site of
signaling and activate a platform for signal transduction. As dis-
cussed earlier, RLR signaling depends on the MAVS adaptor
(Kumar et al., 2006; Sun et al., 2006), which is located on the
limiting membranes of mitochondria, peroxisomes, and the
MAM (Dixit et al., 2010; Horner et al., 2011; Seth et al., 2005).
MAVS localization to each of these compartments is important
for signaling, and it is thought that the MAM provides a scaffold
where peroxisomes and mitochondria dock to create a signaling
platform for antiviral responses. The MAVS-dependent signaling
platform depends on its ability to oligomerize into prion-like
structures that are potent inducers of antiviral gene expression
(Hou et al., 2011). Mislocalizing MAVS to the cytosol renders1174 Cell 151, December 7, 2012 ª2012 Elsevier Inc.cells incapable of inducing RLR signaling (Dixit et al., 2010;
Seth et al., 2005) even though these conditions do not prevent
14-3-3ε-dependent delivery of RLR to these signaling organelles
(Liu et al., 2012). Thus, as was observed for TLR4, microbe-
induced transport of RLRs is not sufficient for signal trans-
duction. The sorting adaptor MAVS must be localized in the
appropriate organelle(s) in order to detect the receptor and
assemble a platform for signal transduction.
It should be noted that most biochemical studies on the local-
ization and signaling functions of MAVS cannot distinguish its
actions on the aforementioned organelles, as ‘‘mitochondria-
enriched membrane fractions’’ are highly contaminated with
peroxisomes and MAM (Horner et al., 2011). Additional work is
therefore needed to determine whether common or distinct
mechanisms of signaling platform assembly occur on each
MAVS-containing compartment. This issue of compartment-
specific signaling is important, as MAVS induces the expression
of different antiviral factors when localized to either mitochondria
or peroxisomes. For example, mitochondrial MAVS induces the
expression of type I IFNs and ISGs, whereas peroxisomal MAVS
induce ISG expression independently of type I IFNs (Dixit et al.,
2010). How (and why) RLRs induce different signaling pathways
from each compartment remains unknown, but it is intriguing
to consider this question in the context of the TLR pathways,
which also induce location-specific transcriptional responses.
For example, at the cell surface, TLR activation induces the
expression of NF-kB-dependent cytokines, whereas endosomal
TLRs induce both cytokine and type I IFN expression (Barton and
Kagan, 2009). Thus, for both the TLRs and RLRs, the site of
signaling determines the type of transcriptional response acti-
vated during a host-microbe encounter.
The role of sorting adaptors in the control of innate immunity
may extend beyond mammals. In the fruit fly Drosophila
melanogaster, antibacterial defenses are governed by a Toll-
signaling pathway that is similar to the mammalian network
(Hoffmann, 2003). Like in mammals, the receptor-proximal
regulators are adaptor proteins, one of which is called Tube
and the other dMyD88. These adaptors mediate the assembly
of a signaling platform consisting of serine/threonine kinases
that activate NF-kB (Sun et al., 2002). Although dMyD88 was
named for its structural similarities to the mammalian MyD88
protein (Horng and Medzhitov, 2001; Tauszig-Delamasure
et al., 2002), dMyD88 exhibits all of the cell biological properties
of the sorting adaptor TIRAP (Marek and Kagan, 2012). dMyD88
is localized to PI(4,5)P2-rich regions of the plasma membrane
prior to any microbial encounter, and it acts to recruit its down-
stream partner Tube to this location. Also, like all other sorting
adaptors, mislocalizing dMyD88 by ablating its lipid binding
motif results in flies that are defective for Toll signaling and anti-
bacterial immunity (Marek and Kagan, 2012). Thus, it appears
that the Toll-signaling pathway follows similar cell biological
principles as the mammalian network. It remains to be deter-
mined whether Toll must be inducibly recruited to PI(4,5)P2-
rich regions of the cell surface to engage the sorting adaptor
dMyD88.
There are some innate immune signaling pathways that are
not yet understood enough to reliably predict where signal
transduction occurs and whether any regulator of signaling has
sorting adaptor functions. For example, based on the ability of
Dectins to regulate phagocytosis (Goodridge et al., 2012),
signaling from the plasma membrane is certain to occur, but
whether transport into subdomains of the cell surface are neces-
sary for signaling is unclear. As such, it is not known whether
any microbe-inducible trafficking factors or sorting adaptors
control Dectin signaling. Similarly, although the IFI16-dependent
signaling pathway activated by DNA viruses requires microbe-
induced transport from the nucleus to the cytosol, which protein
is actually transported is unknown.
Benefits of Separating the Site of Ligand Binding
from the Site of Signal Transduction
What would be the benefit to the cell of separating the sites of
ligand binding from the sites of signal transduction? One of the
central tenets of signal transduction is that ligand recognition
often leads to the inducible oligomerization of receptors by
a process referred to as induced proximity. The simplicity of
induced proximity as a means to activate immune signal trans-
duction likely explains its widespread use among diverse
families of PRRs. However, transmembrane receptors can
oligomerize at several stages of their ‘‘life cycle.’’ For example,
simultaneous binding of multiple TLRs by a single folding
chaperone or trafficking factor (e.g., Unc93B1) would create
a situation whereby the cytosolic TIR domains may also oligo-
merize. Because numerous experimental means of oligomeriz-
ing TLRs are sufficient to induce signal transduction, such as
using chimeric receptors or crosslinking antibodies (Latz et al.,
2002; Medzhitov et al., 1997), it does not appear that TLRs can
distinguish mistaken from microbe-directed receptor oligomeri-
zation. Thus, when considered in the context of an intact cell,
the induced proximity mechanism of signaling activation comes
with significant regulatory challenges. How is signaling by innate
immune receptors permitted only when the receptor is in the
proper subcellular compartment?
I propose that, within cells, specific checkpoints exist that
distinguish biosynthetic from microbe-induced receptor oligo-
merization. One such checkpoint may be the obligatory separa-
tion of the subcellular sites of microbe detection and the sites of
signal transduction. By making sorting adaptor localization the
determinant of signaling, rather than PRR localization, the cell
avoids the problem of distinguishing oligomerization as a result
of microbe detection from some biosynthetic trafficking event.
The benefits described above may also explain the behavior
of nonimmune signaling receptors, such as epidermal growth
factor (EGF) receptor family members. EGF engages its recep-
tor(s) at the plasmamembrane, an event that leads to the recruit-
ment of an adaptor protein called KSR1. KSR1 functions to
induce the Ras-dependent activation of ERK. EGFR is then
internalized into the endosomal network, where it encounters
a second adaptor protein called MP1 (Teis et al., 2002). MP1 is
recruited to late endosomes by the adaptor protein p14, and
both function to induce a second wave of ERK activation from
endosomes (Teis et al., 2002). Interestingly, ERK signaling from
endosomes is essential for cell proliferation and early embryonic
development (Teis et al., 2006). Thus, like the PRR families
described above, some EGFR-induced cellular responses
require the transport of the receptor to a subcellular site thatdiffers from the site of ligand binding. It is possible that this
signaling network also evolved to separate the sites of ligand
binding and signal transduction to ensure the fidelity of signaling
pathway activation, an event that is most critical when consid-
ering the role of ERK in cellular homeostasis and development.
These data are similar to those generated from studies demon-
strating that G-protein-coupled receptors (GPCRs) often must
be endocytosed to promote signal transduction (Kovacs et al.,
2009).
Overall, the separation of the sites of ligand binding from signal
transduction appears to be a fundamental property of cellular
signal transduction pathways and not just a peculiarity of
immune signaling events. It should be stated, however, that
this property does not apply to all signaling receptors. In fact,
exceptions to this idea come from the study of signaling recep-
tors that detect transmembrane proteins found on other cells,
such as B cell receptors and T cell receptors. In these instances,
the physical anchoring of a ligand on another cell may preclude
the signaling receptor from undergoing the subsequent traf-
ficking events. Thus, alternative mechanisms of ensuring the
fidelity of signal transduction likely exist, such as the ligand-
dependent exclusion of negative regulatory factors in the case
of T cell receptors (Rhee and Veillette, 2012).Genetic and Cell Biological Rules of Innate Immune
Signal Transduction
In this Perspective, I proposed the existence of what appears to
be cell biological ‘‘rules’’ that determine the subcellular sites of
innate immune signal transduction. Rule one dictates that, in
order to execute their proinflammatory functions, PRRsmust first
be delivered to the most likely site of PAMP detection. Upon
microbial detection, PRRsmust then be delivered to an organelle
that is permissive for signaling platform assembly (as defined by
the presence of a sorting adaptor). These cell biological rules are
useful because they help to categorize proteins such as CD14,
AP-3, and 14-3-3ε into a group called microbe-inducible traf-
ficking factors. These proteins bear no similarity at the domain
level, but they all function to regulate the microbe-induced traf-
ficking of PRRs to a signaling organelle. Likewise, the sorting
adaptors TIRAP, TRAM, MAVS, dMyD88, and IL-1RacP share
little sequence homology, yet they all function to define a given
organelle as a site of innate immune signal transduction.
I propose that, for every (most) innate immune signaling
pathway(s), a microbe-induced trafficking factor exists to deliver
a PRR to a sorting adaptor. The sorting adaptor then functions
to recruit and assemble an innate immune signaling platform
that permits signal transduction to occur. This model mandates
that the rate of membrane (or protein) trafficking into and out
of a signaling organelle would dictate the intensity or speed of
signaling pathway activation. In this regard, a greater use of
cell biological tools will likely reveal additional principles that
help to classify structurally diverse but functionally related signal
transduction pathways.
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